NEW YORK, Feb. 23 (GenomeWeb News) - CombiMatrix and Benitec announced yesterday that they have entered into a cross-licensing agreement covering a variety of projects.

Through the agreement, CombiMatrix will issue a non-exclusive license to Benitec for its intellectual property rights related to the use of pools of siRNAs, or cocktails, as therapeutic agents against viral diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.